(Q34261346)

1 August 2017

1 reference

title

The possible role and application of WT1 in human leukemia (English)

1 reference

1 August 2017

1 reference

Chen Z

1

1 reference

1 August 2017

publication date

1 January 2001

1 reference

International Journal of Hematology

1 August 2017

published in

1 reference

1 August 2017

volume

73

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

39-46

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02981901

1 August 2017

exact match

0 references

cites work

DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02981901

Mutation analysis of the WT1 gene in myelodysplastic syndromes.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02981901

Mutations in the Wilms' tumor gene WT1 in leukemias

21 January 2018

1 reference

12 December 2020

Mutation analysis of the WT1 gene in sporadic childhood leukaemia

1 reference

12 December 2020

Chromatin remodeling and transcriptional regulation

1 reference

12 December 2020

Dominant-negative mutations of the Wilms' tumour predisposing gene (WT1) are infrequent in CML blast crisis and de novo acute leukaemia.

1 reference

12 December 2020

Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70

1 reference

12 December 2020

Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis

1 reference

12 December 2020

Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing

1 reference

12 December 2020

WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia

1 reference

12 December 2020

Wilms' tumour gene (wt1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol

1 reference

12 December 2020

Wilms tumor gene (wt1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors

1 reference

12 December 2020

Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product

1 reference

12 December 2020

Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain

1 reference

12 December 2020

Cancer immunotherapy targeting Wilms' tumor gene WT1 product

1 reference

12 December 2020

WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes

1 reference

12 December 2020

Differential splicing of exon 5 of the Wilms tumour (WTI) gene

1 reference

12 December 2020

Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells

1 reference

12 December 2020

A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.

1 reference

12 December 2020

Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology

1 reference

12 December 2020

The candidate Wilms' tumour gene is involved in genitourinary development

1 reference

12 December 2020

Downregulation of Wilms' tumor gene (WT1) is not a prerequisite for erythroid or megakaryocytic differentiation of the leukemic cell line K562.

1 reference

12 December 2020

Detection by monoclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemia

1 reference

12 December 2020

The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis

1 reference

12 December 2020

How can oncogenic transcription factors cause cancer: a critical review of the myb story

1 reference

12 December 2020

The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor

1 reference

12 December 2020

Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1

1 reference

12 December 2020

An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling.

1 reference

12 December 2020

Induction of p21 by the Wilms' tumor suppressor gene WT1

1 reference

12 December 2020

The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

1 reference

12 December 2020

Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB.

1 reference

12 December 2020

Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia

1 reference

12 December 2020

WT1 contributes to leukemogenesis: expression patterns in 7,12-dimethylbenz[a]anthracene (DMBA)-induced leukemia.

1 reference

12 December 2020

Transactivation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb

1 reference

12 December 2020

The Wilms' tumor 1 gene: oncogene or tumor suppressor gene?

1 reference

12 December 2020

High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome

1 reference

12 December 2020

Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.

1 reference

12 December 2020

Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.

1 reference

12 December 2020

GATA-1 transactivates the WT1 hematopoietic specific enhancer

1 reference

12 December 2020

Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance.

1 reference

12 December 2020

Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis.

1 reference

12 December 2020

RNA binding by the Wilms tumor suppressor zinc finger proteins.

1 reference

12 December 2020

A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function

1 reference

12 December 2020

Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels

1 reference

12 December 2020

Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1

1 reference

12 December 2020

Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition

1 reference

12 December 2020

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia

1 reference

12 December 2020

Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour

1 reference

12 December 2020

The Wilms tumour (WT1) gene is mutated in a secondary leukaemia in a WAGR patient

1 reference

12 December 2020

Multiple roles for the Wilms' tumor suppressor, WT1.

1 reference

12 December 2020

WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.

1 reference

12 December 2020

Physical and functional interaction between WT1 and p53 proteins

1 reference

12 December 2020

Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.

1 reference

12 December 2020

Expression of the Wilms' tumor suppressor gene, WT1, is upregulated by leukemia inhibitory factor and induces monocytic differentiation in M1 leukemic cells

1 reference

12 December 2020

Secondary leukemia following successful treatment of Wilms' tumor

1 reference

12 December 2020

The role of WT1 in Wilms tumorigenesis

1 reference

12 December 2020

Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript

1 reference

12 December 2020

Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia

1 reference

12 December 2020

Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program

1 reference

12 December 2020

Identification of a tumor-specific methylation site in the Wilms tumor suppressor gene

1 reference

12 December 2020

Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter

1 reference

12 December 2020

HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02981901

1 reference

Dimensions Publication ID

1 August 2017

1052139565

0 references

1 reference